SCHEMBL25671920

SCHEMBL25671920

c1ncc(C2CNCCN2)cn1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 7/20 0.37
CHRNA4 P43681 7/20 0.37
CHRNA7 P36544 3/20 0.37
CHRNB4 P30926 4/20 0.37
CHRNA3 P32297 4/20 0.37
MEN1 O00255 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2C9 P11712 1/20 0.36
PARP1 P09874 1/20 0.32
ROCK2 O75116 1/20 0.31
ROCK1 Q13464 1/20 0.31
HTR2A P28223 2/20 0.30
HTR2C P28335 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38661306 0.79 CHRNB2 (0.62) CHRNB2CHRNA4CHRNA7CHRNA3MEN1
SCHEMBL9592443 0.79 CHRNB2 (0.62) CHRNB2CHRNA4CHRNA7CHRNA3MEN1
SCHEMBL27610284 0.77 CHRNB2 (0.33) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
SCHEMBL8804137 0.76 RECQL (0.39) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL13114845 0.73 CHRNB2 (0.65) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
SCHEMBL21193413 0.73 ROCK2 (0.32) PARP1ROCK2ROCK1
SCHEMBL9271325 0.72 PARP1 (0.32) PARP1
SCHEMBL451612 0.71 SLC18A3 (0.43) MEN1KMT2ACYP2C9
SCHEMBL1638075 0.71 SLC18A3 (0.43) MEN1KMT2ACYP2C9
SCHEMBL1639225 0.71 SLC18A3 (0.43) MEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023105491-A1 5,6,7,8-TETRAHYDRO-2,6-NAPHTHYRIDINE DERIVATIVES AS CANCER THERAPEUTICS VRISE THERAPEUTICS, INC. (US) 2023-06-15 WO disclosed